RHOA and breast cancer: In addition to reducing RSU1, miR-182-5p promotes tumor cell proliferation, invasion and migration by targeting FOXF2, RECK and MTSS1 [61], and the suppression of MTSS1 (MIM) by miR-182 activates RhoA and promotes breast cancer metastasis [63].